Effect of cyp3a5 and abcb1 polymorphisms on dose requirement and trough concentration of tacrolimus in renal transplant recipients

被引：0
|
作者：
Yildirim, E. [1 ]
Sahin, G. [2 ]
Kaltus, Z. [1 ]
Colak, E. [3 ]
机构：
[1] Eskisehir Osmangazi Univ, Fac Med, Med Pharmacol, Eskisehir, Turkey
[2] Eskisehir Osmangazi Univ, Fac Med, Nephrol, Eskisehir, Turkey
[3] Eskisehir Osmangazi Univ, Fac Med, Biostat, Eskisehir, Turkey
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2019年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
EACPT-1194
引用
收藏
页码：S84 / S85
页数：2
相关论文
共 50 条
  • [1] Effect of CYP3A5 and ABCB1 Gene Polymorphisms on Tacrolimus Blood Concentration in Renal Transplant Recipients
    Yildirim, Engin
    Sahin, Garip
    Kaltus, Zuhal
    Colak, Ertugrul
    CLINICAL LABORATORY, 2019, 65 (11) : 2079 - 2089
  • [2] Association study of ABCB1 and CYP3A5 gene polymorphisms with sirolimus trough concentration and dose requirements in Chinese renal transplant recipients
    Miao, Li-Yan
    Huang, Chen-Rong
    Hou, Jian-Quan
    Qian, Mei-Ying
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2008, 29 (01) : 1 - 5
  • [3] Dynamic effects of CYP3A5 polymorphism on dose requirement and trough concentration of tacrolimus in renal transplant recipients
    Chen, P.
    Li, J.
    Li, J.
    Deng, R.
    Fu, Q.
    Chen, J.
    Huang, M.
    Chen, X.
    Wang, C.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (01) : 93 - 97
  • [4] CYP3A5 and CYP3A4, but not ABCB1 polymorphisms affect tacrolimus dose-adjusted trough concentrations in kidney transplant recipients
    Kurzawski, Mateusz
    Dabrowska, Justyna
    Dziewanowski, Krzysztof
    Domanski, Leszek
    Peruzynska, Magdalena
    Drozdzik, Marek
    PHARMACOGENOMICS, 2014, 15 (02) : 179 - 188
  • [5] Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients
    Tsuchiya, N
    Satoh, S
    Tada, H
    Li, ZH
    Ohyama, C
    Sato, K
    Suzuki, T
    Habuchi, T
    Kato, T
    TRANSPLANTATION, 2004, 78 (08) : 1182 - 1187
  • [6] CYP3A7, CYP3A5, CYP3A4, and ABCB1 Genetic Polymorphisms, Cyclosporine Concentration, and Dose Requirement in Transplant Recipients
    Crettol, Severine
    Venetz, Jean-Pierre
    Fontana, Massimiliano
    Aubert, John-David
    Pascual, Manuel
    Eap, Chin B.
    THERAPEUTIC DRUG MONITORING, 2008, 30 (06) : 689 - 699
  • [7] Influence of CYP3A5 and MDR1(ABCB1) Polymorphisms on the Pharmacokinetics of Tacrolimus in Chinese Renal Transplant Recipients
    Rong, G.
    Jing, L.
    Deng-Qing, L.
    Hong-Shan, Z.
    Shai-Hong, Z.
    Xin-Min, N.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3455 - 3458
  • [8] CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients
    Li, Yi
    Yan, Lin
    Shi, Yunying
    Bai, Yangjuan
    Tang, Jiangtao
    Wang, Lanlan
    SPRINGERPLUS, 2015, 4
  • [9] The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients
    Haufroid, V
    Mourad, M
    Van Kerckhove, V
    Wawrzyniak, J
    De Meyer, M
    Eddour, DC
    Malaise, J
    Lison, D
    Squifflet, JP
    Wallemacq, P
    PHARMACOGENETICS, 2004, 14 (03): : 147 - 154
  • [10] EFFECT OF CYP3A5, CYP3A4, POR AND ABCB1 POLYMORPHISMS ON TACROLIMUS METABOLISM IN RENAL TRANSPLANT PATIENTS
    Chong, Winnie
    Hamilton-Jones, Siobhan
    Kim, Jon Jin
    Navarrete, Cristina V.
    Key, Tim
    Howell, Martin W.
    HLA, 2020, 95 (04) : 316 - 316
12345